Cargando…

Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

Detalles Bibliográficos
Autores principales:	Pather, Shanti, Madhi, Shabir A., Cowling, Benjamin J., Moss, Paul, Kamil, Jeremy P., Ciesek, Sandra, Muik, Alexander, Türeci, Özlem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292686/ https://www.ncbi.nlm.nih.gov/pubmed/37377964 http://dx.doi.org/10.3389/fimmu.2023.1232965

Ejemplares similares

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
por: Pather, Shanti, et al.
Publicado: (2023)

The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
por: McLean, Gary, et al.
Publicado: (2022)

Addressing COVID-19 vaccine hesitancy
por: Kassianos, George, et al.
Publicado: (2022)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
por: Quandt, Jasmin, et al.
Publicado: (2022)

COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review
por: Fergie, Jaime, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

COVID vaccine booster doses for omicron variants
por: Burki, Talha
Publicado: (2022)

Omicron variant evolution on vaccines and monoclonal antibodies
por: Sabbatucci, Michela, et al.
Publicado: (2023)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
por: Jacobsen, Henning, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant: viral spread dynamics, disease burden, and vaccine effectiveness
por: Sun, Shengzhi, et al.
Publicado: (2022)

Reproduction Number of the Omicron Variant Triples That of the Delta Variant
por: Du, Zhanwei, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Could Beta variant containing COVID-19 booster vaccines tackle Omicron variants?
por: Jin, Pengfei, et al.
Publicado: (2023)

Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
por: Zang, Jinkai, et al.
Publicado: (2022)

Population Immunity and Covid-19 Severity with Omicron Variant in South Africa
por: Madhi, Shabir A., et al.
Publicado: (2022)

Changes in COVID-19 CT Manifestations with Vaccination and the Omicron Variant
por: Yoon, Soon Ho, et al.
Publicado: (2023)

Antiviral Drugs and Vaccines for Omicron Variant: A Focused Review
por: Garg, Nidhi, et al.
Publicado: (2023)

Benefit–risk evaluation of COVID-19 vaccination in special population groups of interest
por: Moss, Paul, et al.
Publicado: (2022)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
por: Muik, Alexander, et al.
Publicado: (2022)

Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant
por: Higdon, Melissa M, et al.
Publicado: (2022)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

Modeling the Impact of Vaccination on COVID-19 and Its Delta and Omicron Variants
por: Wang, Jianbo, et al.
Publicado: (2022)

Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women
por: Kim, Haemin, et al.
Publicado: (2023)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Third booster vaccination and stopping the Omicron, a new variant of concern
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
por: Bojkova, Denisa, et al.
Publicado: (2022)

Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant
por: Khan, Khadija, et al.
Publicado: (2022)

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
por: Ao, Danyi, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England
por: Kirsebom, Freja C M, et al.
Publicado: (2022)

Comparative analysis of transmission and vaccine effectiveness in Omicron and Delta variant outbreaks in China
por: Li, Kangguo, et al.
Publicado: (2023)

The potential of Beta variant containing COVID booster vaccines for chasing Omicron in 2022
por: Sridhar, Saranya, et al.
Publicado: (2022)

COVID-19 Vaccines against Omicron Variant: Real-World Data on Effectiveness
por: Kherabi, Yousra, et al.
Publicado: (2022)

Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
por: Chavda, Vivek P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fq1o6tre9kao7jscqlh6omsuo2